Integral Derivatives’s Humana HUM Stock Holding History

Integral Derivatives’s Portfolio HUM Stock Details HUM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	$565K	Sell	2,100 -4,200	-67%	-$1.14M	0.01%	357
2017 Q4	$1.56M	Buy	6,300 +200	+3%	+$49.4K	0.03%	354
2017 Q3	$1.49M	Sell	6,100 -1,100	-15%	-$270K	0.03%	384
2017 Q2	$1.73M	Buy	7,200 +1,300	+22%	+$294K	0.04%	336
2017 Q1	$1.22M	Sell	5,900 -5,400	-48%	-$1.12M	0.02%	461
2016 Q4	$2.31M	Buy	11,300 +7,700	+214%	+$1.47M	0.04%	288
2016 Q3	$637K	Buy	3,600 +1,600	+80%	+$278K	0.01%	560
2016 Q2	$360K	Buy	+2,000	New	+$355K	0.01%	692
2016 Q1	–	Sell	-4,400	Closed	-$785K	–	973
2015 Q4	$785K	Hold	4,400	–	–	0.02%	541
2015 Q3	$788K	Buy	+4,400	New	+$813K	0.02%	569

Other funds holding HUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Integral Derivatives's HUM Position: Q1 2018 in Review

Integral Derivatives sold out of Humana (HUM) in Q1 2018, closing a stake of 2,638 shares — an estimated $714K sold.

Integral Derivatives first reported a position in HUM in Q1 2014 and held it in 8 quarters. The position peaked at $1.82M in Q2 2017. 682 funds tracked by Wall St. Rank hold HUM as of Q1 2018.

Integral Derivatives reported no remaining Humana position as of Q1 2018 after selling out during the quarter.
Integral Derivatives sold 2,638 Humana shares in Q1 2018, an estimated $714K.
Integral Derivatives first reported a position in Humana in Q1 2014 and held it in 8 quarters.
Integral Derivatives's Humana position peaked at $1.82M in Q2 2017.
682 funds tracked by Wall St. Rank held Humana as of Q1 2018.

Based on Integral Derivatives's 13F filing for Q1 2018, filed 19 Apr 2018.